<DOC>
	<DOCNO>NCT00751764</DOCNO>
	<brief_summary>The purpose study evaluate extent moxidectin transfer breast milk lactate woman provide initial pharmacokinetic safety profile moxidectin lactate woman .</brief_summary>
	<brief_title>Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating , Non-Breastfeeding Women</brief_title>
	<detailed_description />
	<mesh_term>Milbemycin</mesh_term>
	<criteria>Inclusion criterion : Healthy lactate woman age 21 45 year inclusive screening . Women : Be least 12weeks postpartum uncomplicated delivery full milk supply establish . Be willing discontinue breastfeed permanently process wean infant . Care take ensure subject discontinue breastfeed infant order participate study . Not plan breastfeed within 9 month study drug administration . Be willing fully express breast milk breast duration milk collection portion study . Subjects must able express milk breast pump session use breast pump . Body mass index range 18 35 kg/m2 . Exclusion criterion : Presence history disorder may prevent successful completion study . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>